Chebu Pharmaceutical Limited

Antirheumatic drug developed by Chebu is a novel product that does not fall into existing arthritis medication therapeutic categories.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Nairobi, Kenya
  • Currency KES
  • Founded June 2011
  • Employees 15
  • Incorporation Type C-corp

Company Summary

CPL was incorporated on 7th June 2011 in the Republic of Kenya. Its core financial interests are in the healthcare and pharmaceutical industries, with focus on new arthritis medication discoveries and development. CPL intends to commercialize a rheumatoid arthritis medication during the next expansion phase commencing in January 2019. This medication is currently in liquid form.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free